178 related articles for article (PubMed ID: 24559447)
1. Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.
Mooney R; Weng Y; Tirughana-Sambandan R; Valenzuela V; Aramburo S; Garcia E; Li Z; Gutova M; Annala AJ; Berlin JM; Aboody KS
Future Oncol; 2014 Feb; 10(3):401-15. PubMed ID: 24559447
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors.
Cao P; Mooney R; Tirughana R; Abidi W; Aramburo S; Flores L; Gilchrist M; Nwokafor U; Haber T; Tiet P; Annala AJ; Han E; Dellinger T; Aboody KS; Berlin JM
Bioconjug Chem; 2017 Jun; 28(6):1767-1776. PubMed ID: 28453256
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.
Alizadeh D; Zhang L; Hwang J; Schluep T; Badie B
Nanomedicine; 2010 Apr; 6(2):382-90. PubMed ID: 19836468
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H
Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
[TBL] [Abstract][Full Text] [Related]
8. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
[TBL] [Abstract][Full Text] [Related]
9. Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
Cheng SH; Yu D; Tsai HM; Morshed RA; Kanojia D; Lo LW; Leoni L; Govind Y; Zhang L; Aboody KS; Lesniak MS; Chen CT; Balyasnikova IV
J Nucl Med; 2016 Feb; 57(2):279-84. PubMed ID: 26564318
[TBL] [Abstract][Full Text] [Related]
10. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography.
Chertok B; David AE; Yang VC
J Control Release; 2011 Nov; 155(3):393-9. PubMed ID: 21763736
[TBL] [Abstract][Full Text] [Related]
11. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
12. Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model.
Barish ME; Herrmann K; Tang Y; Argalian Herculian S; Metz M; Aramburo S; Tirughana R; Gutova M; Annala A; Moats RA; Goldstein L; Rockne RC; Gutierrez J; Brown CE; Ghoda L; Aboody KS
Stem Cells Transl Med; 2017 Jun; 6(6):1522-1532. PubMed ID: 28481046
[TBL] [Abstract][Full Text] [Related]
13. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
14. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
[TBL] [Abstract][Full Text] [Related]
15. Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas.
Wadajkar AS; Dancy JG; Roberts NB; Connolly NP; Strickland DK; Winkles JA; Woodworth GF; Kim AJ
J Control Release; 2017 Dec; 267():144-153. PubMed ID: 28887134
[TBL] [Abstract][Full Text] [Related]
16. Mathematical modeling of therapeutic neural stem cell migration in mouse brain with and without brain tumors.
Gomez J; Holmes N; Hansen A; Adhikarla V; Gutova M; Rockne RC; Cho H
Math Biosci Eng; 2022 Jan; 19(3):2592-2615. PubMed ID: 35240798
[TBL] [Abstract][Full Text] [Related]
17. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
18. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.
Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q
Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer.
He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY
J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy.
Cheng Y; Morshed R; Cheng SH; Tobias A; Auffinger B; Wainwright DA; Zhang L; Yunis C; Han Y; Chen CT; Lo LW; Aboody KS; Ahmed AU; Lesniak MS
Small; 2013 Dec; 9(24):4123-9. PubMed ID: 23873826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
